Eli Lilly

Eli Lilly's Covid-19 partner AbCellera pays $90M for some very special mice as IPO rumors heat up
Endpoints
Thu, 11/19/20 - 10:21 am
AbCellera
Eli Lilly
Regeneron
Trianni
monoclonal antibodies
How Effective Will Lilly’s Bamlanivimab be in the Battle Against COVID-19?
BioSpace
Mon, 11/16/20 - 10:08 am
Eli Lilly
bamlanivimab
LY-CoV555
COVID-19
antibodies
Shortage of monkeys slowed down Eli Lilly's Covid-19 antibody partner. And it's a problem for everyone
Endpoints
Fri, 11/13/20 - 12:59 pm
COVID-19
animal studies
clinical trials
antibodies
Eli Lilly
Shanghai Junshi Biosciences
Lilly backs a biotech's spinout and places a small bet on protein degradation
BioPharma Dive
Fri, 11/13/20 - 12:36 pm
Eli Lilly
Seed Therapeutics
protein degradation
Eli Lilly Designs P-Tau Biomarker Assay for Early Alzheimer’s Disease Diagnosis
BioSpace
Wed, 11/11/20 - 11:09 pm
Eli Lilly
Alzheimer's disease
biomarker assays
biomarkers
diagnostics
P-tau
Feds Will Start Distributing Eli Lilly Covid-19 Antibody Treatment This Week
Forbes
Tue, 11/10/20 - 07:49 pm
HHS
Alex Azar
antibodies
COVID-19
Eli Lilly
Eli Lilly gets FDA EUA status for bamlanivimab to treat Covid-19
Pharmaceutical Business Review
Tue, 11/10/20 - 10:44 am
Eli Lilly
Emergency Use Authorizations
FDA
LY-CoV-55
COVID-19
antibodies
After Pfizer's vaccine data, analysts say COVID19 drugmakers face questions about long-term sales prospects
Fierce Pharma
Mon, 11/9/20 - 08:51 pm
Pfizer
BioNTech
Gilead Sciences
Eli Lilly
Regeneron
COVID-19
pharma stocks
vaccines
clinical trials
Why AstraZeneca, Bristol Myers Squibb, and Eli Lilly Stocks Jumped Today
Motley Fool
Wed, 11/4/20 - 11:02 pm
pharma stocks
2020 Presidential election
Eli Lilly
Bristol-Myers Squibb
AstraZeneca
EADV 2020: Lilly and Incyte Showcase New Data for Baricitinib for the Treatment of Moderate to Severe Atopic Dermatitis
Yahoo
Sun, 11/1/20 - 01:37 pm
Eli Lilly
Incyte
baricitinib
atopic dermatitis
EADV
Eli Lilly lines up a blockbuster deal for Covid-19 antibody, right after it failed a NIAID trial
Endpoints
Wed, 10/28/20 - 10:40 am
Eli Lilly
antibodies
COVID-19
FDA
government contract
Care Access Research, Lilly join on mobile COVID-19 trials
Biopharma Reporter
Tue, 10/27/20 - 11:21 pm
Eli Lilly
Care Access Research
COVID-19
clinical trials
Eli Lilly Ends Covid-19 Antibody Trial After Finding It’s Unlikely To Help Hospitalized Patients
Forbes
Mon, 10/26/20 - 11:20 pm
Eli Lilly
antibodies
COVID-19
clinical trials
Eli Lilly may face FDA warning letter after recent inspection at COVID-19 antibody plant found more issues: report
Fierce Pharma
Wed, 10/21/20 - 10:41 am
Eli Lilly
COVID-19
antibodies
drug manufacturing
FDA
Eli Lilly strikes deal to sell R&D campus to UCB
Fierce Biotech
Fri, 10/16/20 - 11:13 am
Eli Lilly
R&D
UK
UCB Pharma
Eli Lilly Acquires Disarm Therapeutics in an Effort to Solve Axonal Degeneration
BioSpace
Thu, 10/15/20 - 10:17 pm
Eli Lilly
axonal degeneration
M&A
Disarm Therapeutics
What The Pause In The Johnson & Johnson And Eli Lilly Covid Drug Trials May Mean
Forbes
Wed, 10/14/20 - 11:05 am
vaccines
JNJ
Eli Lilly
COVID-19
clinical trials
Eli Lilly faces FDA crackdown for manufacturing issues at plant handling COVID-19 antibody
Fierce Pharma
Wed, 10/14/20 - 10:55 am
Eli Lilly
FDA
drug manufacturing
antibodies
COVID-19
Eli Lilly Covid-19 Antibody Treatment Trial Is Paused Due To 'Potential Safety Concern'
Forbes
Tue, 10/13/20 - 09:51 pm
Eli Lilly
clinical trials
COVID-19
antibodies
Eli Lilly taps Fujifilm to chip in on COVID-19 antibody manufacturing as it awaits FDA's emergency use decision
Fierce Pharma
Tue, 10/13/20 - 12:31 pm
Eli Lilly
COVID-19
FDA
antibodies
Fujifilm
drug manufacturing

Pages